This suggests that BCL10 may inhibit the infiltration of CD8+T cells, CD4+Th1 cells, and NKT cells in the TIME by increasing the expression of LAG3 and PDCD1, thereby promoting the progression of CESC. The gene discussed is CD8A; the disease is cervical squamous cell carcinoma.